Organisation: Novartis

A French appellate court has quashed €444 million in fines levied by the country’s antitrust watchdog against Novartis and Roche, ruling that the drugmakers did not abuse their collective dominance by discouraging off-label prescriptions for a cheaper medicine.

17 February 2023

A Turkish court has overturned the national antitrust watchdog’s decision to fine Roche and Novartis over €30 million in combined penalties for conspiring to spread misinformation about a cheaper eye treatment drug, ruling the authority failed to demonstrate illegal collusion.

30 January 2023

The Belgian Competition Authority has fined Novartis €2.8 million after concluding it unlawfully shut out competition in the market for certain eye disease treatments by exaggerating the potential side effects of a rival drug.

25 January 2023